FDA Warning Letter — Sewaren Innovative Pharmaceutical Packaging dba SIPP
The FDA took a Warning Letter action against Sewaren Innovative Pharmaceutical Packaging dba SIPP on May 22, 2017 (Avenel, NJ). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Sewaren Innovative Pharmaceutical Packaging dba SIPP
- Date
- May 22, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Avenel, NJ (United States)